\ BIP! Finder for COVID-19 - Impact-based ranking
Open dataset
Publication

BIP! Finder for COVID-19

Statistics
@BipFinder

This version of BIP! Finder aims to ease the exploration of COVID-19-related literature by enabling ranking articles based on various impact metrics.

Last Update: 18 - 01 - 2023 (628506 entries)

Provided impact measures:
Popularity: Citation-based measure reflecting the current impact.
Influence: Citation-based measure reflecting the total impact.
Reader Attention: The current number of Mendeley readers.
Social Media Attention: The number of recent tweets related to this article.
*More details on these impact measures can be found here.
Score interpretations:
Exceptional score (in top 0.01%).
Substantial score (in top 1%).
Average score (in bottom 99%).
Score not available.
Main data sources:
CORD-19 dataset(1) (list of papers)
LitCovid hub(2) (list of papers)
PMC & PubMed (citations)
Mendeley (number of readers)
COVID-19-TweetIDs(3) (tweets)

Use:  Impact  Relevance & Impact

Rank by:
Popularity Influence Reader Attention Social Media Attention

<< 51 52 53 54 55 >>

TitleVenueYearImpactSource
2601Tozinameran: Multiple evanescent white dot syndrome: case report  

N/A2022       CORD-19
2602Baricitinib/dexamethasone: Myalgia and elevated creatine kinase following an off-label use: case report  

N/A2022       CORD-19
2603Warning against consumption of Miracle Mineral Solution  

N/A2022       CORD-19
2604Elasomeran: Acute corneal transplant rejection: case report  

N/A2022       CORD-19
2605Covid-19-vaccine: Exacerbation of chronic graft vs host disease: 9 case reports  

N/A2022       CORD-19
2606Multiple drugs: Delayed allergic reaction and various other toxicities: case report  

N/A2022       CORD-19
2607Tozinameran: Bullous pemphigoid: case report  

N/A2022       CORD-19
2608Dexamethasone/voriconazole: Invasive aspergillosis following off-label use; lack of efficacy: case report  

N/A2022       CORD-19
2609Lopinavir/ritonavir delays COVID-19 recovery in pediatric patients  

N/A2022       CORD-19
2610Elasomeran: Perimyocarditis: case report  

N/A2022       CORD-19
2611Levofloxacin: First report of symmetric drug-related intertriginous and flexural exanthema: case report  

N/A2022       CORD-19
2612Cardiac risks higher after COVID-19 infection than mRNA vaccine  

N/A2022       CORD-19
2613Methylprednisolone/peg-3350/sodium-chloride/sodium-bicarbonate/potassium-chloride/phenoxymethylpenicillin: Anaphylaxis to the polyethylene glycol (PEG) excipients: 2 case reports  

N/A2022       CORD-19
2614AZD-1222/tozinameran: Varicella zoster virus induced neurological disease: 3 case reports  

N/A2022       CORD-19
2615Anticoagulants/AZD-1222: Vaccine induced immune thrombotic thrombocytopenia and treatment failure: case report  

N/A2022       CORD-19
2616Coronavirus-vaccine: Supraclavicular lymphadenopathy: 2 case reports  

N/A2022       CORD-19
2617Elasomeran/tozinameran: Progression of autoimmune skin disease to new onset sclerotic skin disease: 2 case reports  

N/A2022       CORD-19
2618Remdesivir: Elevated aspartate aminotransferase and alanine aminotransferase levels: case report  

N/A2022       CORD-19
2619Antibacterials/convalescent-anti-SARS-CoV-2-plasma/hydroxychloroquine: Off-label use and lack of efficacy: case report  

N/A2022       CORD-19
2620Ad26.COV2-S/elasomeran/tozinameran: Myocarditis: 7 case reports  

N/A2022       CORD-19
2621COVID-19-vaccines/immune-globulin/methylprednisolone: Immune associated CNS-disorders, inflammatory disorders and no therapeutic response: 5 case reports  

N/A2022       CORD-19
2622Baricitinib/propofol: Pancreatitis following off-label use: case report  

N/A2022       CORD-19
2623Hydroxychloroquine: Premature ventricular complexes and ventricular tachycardia following off-label use: 3 case reports  

N/A2022       CORD-19
2624Sevoflurane: Nephrogenic diabetes insipidus following off-label use: case report  

N/A2022       CORD-19
2625Multiple drugs: Lack of efficacy and off label treatment: case report  

N/A2022       CORD-19
2626Teriflunomide: Lack of efficacy: case report  

N/A2022       CORD-19
2627Multiple drugs: Various toxicities: case report  

N/A2022       CORD-19
2628Elasomeran/tozinameran: Myocarditis, perimyocarditis and pericarditis: 16 case reports  

N/A2022       CORD-19
2629Casirivimab/imdevimab: Various toxicities: 2 case reports  

N/A2022       CORD-19
2630Tozinameran: Interstitial pneumonitis: 3 case reports  

N/A2022       CORD-19
2631Tozinameran: Bullous pemphigoid: case report  

N/A2022       CORD-19
2632BBIBP-CorV: Acute disseminated encephalomyelitis: case report  

N/A2022       CORD-19
2633COVID-19-Vaccine-Pfizer-BioNTech/elasomeran: Subacute thyroiditis and Graves' disease: 3 case reports  

N/A2022       CORD-19
2634Tozinameran: Medium-vessel vasculitis and acute anterior uveitis: case report  

N/A2022       CORD-19
2635Other adverse reaction research  

N/A2022       CORD-19
2636Ciclosporin/prednisone: Visceral leishmaniasis: case report  

N/A2022       CORD-19
2637PRAC meeting highlights April 2022: no link between mRNA COVID-19 vaccines and autoimmune hepatitis  

N/A2022       CORD-19
2638Covid-19-vaccine-pfizer-biontech/prednisone/valaciclovir: Oculomotor nerve palsy and no improvement: case report  

N/A2022       CORD-19
2639COVID-19-Vaccine-Pfizer-BioNTech: Venous thromboembolism: case report  

N/A2022       CORD-19
2640Iopamidol/lidocaine/epinephrine: Anaphylaxis: 2 case reports  

N/A2022       CORD-19
2641Dexamethasone/remdesivir: Lack of efficacy and drug withdrawal: case report  

N/A2022       CORD-19
2642Methylprednisolone: Rhino-facial mucormycosis following off label use: case report  

N/A2022       CORD-19
2643Azithromycin/hydroxychloroquine: Lack of efficacy: 2 case reports  

N/A2022       CORD-19
2644Multiple drugs: Fatal Candida Glabrata infection following off-label use and lack of efficacy: case report  

N/A2022       CORD-19
2645Paracetamol: Lack of efficacy: case report  

N/A2022       CORD-19
2646Azd-1222: Anti-Neutrophil Cytoplasmic Antibody-associated vasculitis: case report  

N/A2022       CORD-19
2647Multiple drugs: Lack of efficacy: case report  

N/A2022       CORD-19
2648Favipiravir: Hyperuricaemia and lack of efficacy following off-label use: 2 case reports  

N/A2022       CORD-19
2649Ciclosporin/tozinameran: Behcet's disease and hepatic damage: 2 case reports  

N/A2022       CORD-19
2650Tozinameran: New onset of remitting seronegative symmetrical synovitis with pitting oedema and palmoplantar psoriasis flare-up: case report  

N/A2022       CORD-19

<< 51 52 53 54 55 >>

(1) COVID-19 Open Research Dataset (CORD-19). 2020. Version 2022-06-02. Retrieved from https://ai2-semanticscholar-cord-19.s3-us-west-2.amazonaws.com/historical_releases.html. Accessed 2022-06-05. doi:10.5281/zenodo.3715506
(2) Chen Q, Allot A, & Lu Z. (2020) Keep up with the latest coronavirus research, Nature 579:193 and Chen Q, Allot A, Lu Z. LitCovid: an open database of COVID-19 literature. Nucleic Acids Research. 2020. (version 2023-01-10)
(3) Currently tweets of June 23rd to June 29th 2022 have been considered.

Copyright ATHENA RC 2020, Developed by: Thanasis Vergoulis, Ilias Kanellos, Serafeim Chatzopoulos, and Danae Pla Karidi
This service is provided "as is", without any warranties of any kind.
We have placed cookies on your device to help make this website and the services we offer better. By using this site, you agree to the use of cookies. Learn more
I accept